Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer - Wikidata - wikimedia - TriplyDB

Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer

Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer

http://www.wikidata.org/entity/Q33715446

about

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines.Potential target antigens for a universal vaccine in epithelial ovarian cancer.NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.LINE-1 and Alu hypomethylation in mucoepidermoid carcinoma.Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.Augmenting antitumor immune responses with epigenetic modifying agents.Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients Epigenetic mechanisms underlying the dynamic expression of cancer-testis genes, PAGE2, -2B and SPANX-B, during mesenchymal-to-epithelial transition.Differential Epigenetic Effects of Atmospheric Cold Plasma on MCF-7 and MDA-MB-231 Breast Cancer Cells.Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications.DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.Proton Beams Inhibit Proliferation of Breast Cancer Cells by Altering DNA Methylation Status BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer.Epigenetic resensitization to platinum in ovarian cancer Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.Promoter methylation and downregulated expression of the TBX15 gene in ovarian carcinoma Association between global DNA hypomethylation in leukocytes and risk of breast cancer.DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11.PRAME expression and promoter hypomethylation in epithelial ovarian cancer.Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients.Inducible expression of cancer-testis antigens in human prostate cancer.Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer.Decitabine: a promising epi-immunotherapeutic agent in solid tumors.Epigenetics: A primer for clinicians.Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts.Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.Distinct roles for histone methyltransferases G9a and GLP in cancer germ-line antigen gene regulation in human cancer cells and murine embryonic stem cells.p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.Cancer-testis antigens are predominantly expressed in uterine leiomyosarcoma compared with non-uterine leiomyosarcoma.Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs.

P2860

Q28075712-C4C16E07-BB0A-4681-9E1C-F3007E2D8218 Q33957165-2F0939C2-AE2A-42F9-80E2-9078DF2C1891 Q34044914-62F623D7-E51C-4F33-A908-60EFA0758E8A Q34159451-8B7F9747-BFB8-452D-B1B7-453458EB0EC4 Q34325790-B422A774-5EAD-4A75-8688-D5BFAA355C48 Q34627497-AB6EC254-986F-4495-8EA2-B4870B6E42D4 Q34810674-772A4F0B-5A9A-4AD4-A59B-4268E9829C23 Q34870799-74CA71A2-A582-41F0-B289-0F25934922EE Q35048054-032501A4-0D24-4EA8-9EE5-BDFA7C79F2D1 Q35069309-C290C731-F30E-49A0-8692-E65A17FA6164 Q35257918-188F3DBD-0791-4E52-9D88-6987F75A9A67 Q35652452-F1F7662B-9C60-452D-8836-D864D2CBFF39 Q35832715-B652CC39-4FF3-42A7-96E3-00938C9A04E7 Q36001900-9C4F1140-84FF-4DF4-9A0E-BFF1B75ED7C6 Q36213219-E264CBB8-FAFE-498F-B81A-3176A1D34E0C Q36214731-25F9DB22-E447-4B27-AC56-53FC2918F485 Q36563924-43914684-F68F-4415-8062-91AC529E73E3 Q36574436-B375FBCA-B38F-41B7-8972-5FE7AA00C6B1 Q36979382-8A18FA17-AE7A-45C8-96C3-C673B84A7C10 Q37022306-E91DE098-1ACA-449F-8BC4-DDEEE93AFF69 Q37082518-4FD5E46A-4ADA-4D94-BABF-19739540A9E3 Q37288673-8ACABD19-5067-42F0-9357-E82721278CC2 Q37437220-302FA867-B2F1-4578-9044-C4DBB12C7FD9 Q37445288-ABA138AF-7D3A-435F-B802-5CF9978E8ED3 Q37564420-33037AD0-6BD0-4C52-B83C-7F781B960802 Q37585487-190E56E2-A4EA-4B0C-9A28-20B74AA3C32E Q37622031-E726236B-4AA5-4426-857D-766173E990E1 Q37686238-C3E1A5EF-4E96-4D78-8D9D-DA1006BCC62E Q37737327-D671631A-4138-4B12-B51F-72A155366552 Q38154781-026F75EC-DB73-4056-9350-DDDA0A384EFE Q38314204-C0A47A30-443B-4044-A6A4-9F4E3D9FC37D Q38770916-C3AF0B2C-7954-431E-8DB0-1BCC3D8A7DCE Q38948541-076D2173-E8AD-4028-BDF8-F2E9017AA3CF Q38952962-7BEA1C4A-6354-4451-8C52-F3E00B878509 Q39337489-9B512030-65DD-4339-9870-CE6AC7255F9C Q39567031-0616BC2B-E8B5-4FF2-829A-53A7D4564F4F Q39916396-2076641F-92A5-4091-9115-1BFB838488F1 Q41550137-E2C78DAB-3EDB-4F7B-BA36-A55A7E257562 Q49335269-0A7C4DAD-90A3-4CA3-82B1-E102B3837450 Q49921990-A3FA5240-48E9-4463-AA42-2236F9D7329B

P2860

Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer

http://www.wikidata.org/entity/Q33715446

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Intertumor and intratumor NY-E ...... ation status in ovarian cancer

@ast

Intertumor and intratumor NY-E ...... ation status in ovarian cancer

@en

type

label

Intertumor and intratumor NY-E ...... ation status in ovarian cancer

@ast

Intertumor and intratumor NY-E ...... ation status in ovarian cancer

@en

prefLabel

Intertumor and intratumor NY-E ...... ation status in ovarian cancer

@ast

Intertumor and intratumor NY-E ...... ation status in ovarian cancer

@en

P1433

Q33715446-12A135E8-6D87-49D5-B7C0-8616BDE1AFCE

P1476

Q33715446-75E2E22F-C144-4222-AEBA-307F041FA5DB

P2093

Q33715446-75470869-C97C-4919-A521-C065703DE5C1

Q33715446-A64CA6D5-A6FE-423D-B684-CCD230DE0471

Q33715446-D635E4D0-6DFE-4FF6-A2A4-639F4AD44757

Q33715446-DEA6CF47-F301-4201-9B19-A26A4D3235BE

P2860

Q33715446-00DC5360-5E3A-46EF-9355-A1D3EAE8FF78

Q33715446-0F1E86F2-D32B-43F0-9AE0-27A433399CA1

Q33715446-102265FD-3359-4C46-8CC4-D38CEE5436FF

Q33715446-136E6D76-49C3-4D75-8C0C-19B4E518B9F9

Q33715446-165619B8-E83E-4074-BB5C-FCB3DDEABA8B

Q33715446-1A54C199-7FB6-4994-B39D-D5D5BBAABD29

Q33715446-1DCCA466-3BC6-4024-8A96-BD94333BD39F

Q33715446-1E230FB1-F0E8-4FC4-964D-5E49B003B9D8

Q33715446-37382DFE-2AB4-4E75-B8B9-EE728EF61719

Q33715446-422BC4CE-BBF4-4246-88ED-6F12DEDD3352

P304

Q33715446-D1EF6E1B-D6FC-4D41-BDF6-CB507B77A7C6

P31

Q33715446-DDCB0B24-9693-4D76-8254-37B3AFF00963

P356

Q33715446-B6F08557-BADD-4BBA-BF67-C6709B20DDD2

P407

Q33715446-7D18211F-2078-4787-BA93-76F268073454

P433

Q33715446-0F1928FF-E114-412C-B735-16E220904021

P478

Q33715446-7AE22DC1-884D-4312-9444-5F7330EDB13F

P50

Q33715446-7689F419-7817-42FD-80A6-E0305100AA94

P577

Q33715446-252C19E9-1A0F-4ECF-9310-EF7D8C12508C

P5875

Q33715446-E69CF90A-5CD9-4671-9A50-FB00B151ACBF

P698

Q33715446-E6160C43-07BB-4BEF-968F-04122F421269

P921

Q33715446-4562F29B-F74F-47A5-A9D4-B29AD278554F

Q33715446-5765CE83-7044-478A-A1FD-925A403487B6

P932

Q33715446-78F231F9-41C0-4F52-BD6D-0498BB714D77

P356

1078-0432.CCR-07-5279

P1433

Clinical Cancer Research

P1476

Intertumor and intratumor NY-E ...... ation status in ovarian cancer

@en

P2093

Adam R Karpf

http://www.w3.org/2001/XMLSchema#string

Anna Woloszynska-Read

http://www.w3.org/2001/XMLSchema#string

Jihnhee Yu

http://www.w3.org/2001/XMLSchema#string

Paulette Mhawech-Fauceglia

http://www.w3.org/2001/XMLSchema#string

P2860

Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells

DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter

DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer

Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

The epigenomics of cancer

Cancer/testis antigens, gametogenesis and cancer

The history of cancer epigenetics

Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry.

Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.

P304

3283-3290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-5279

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51396346

http://www.w3.org/2001/XMLSchema#string

P698

18519754

http://www.w3.org/2001/XMLSchema#string

P921

DNA methylation

P932

2835568

http://www.w3.org/2001/XMLSchema#string